Herpes
Company commences animal trials for antiherpes DNA formulation
Published in Women's Health Weekly, August 28th, 2003
The study is composed of 120 mice in 8 groups. Mice are excellent herpes disease models because they die within a few weeks after infection if left untreated. Preliminary results are expected within 30 days.
"These trials will demonstrate safety and pharmacologic effectiveness prior to human studies. In addition, we are testing our formulation for use as a prophylactic (preventative) as well as a therapeutic for long term cure," stated Dr. Malcolm Skolnick, CytoGenix's president/CEO.
"Existing herpes treatments do...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Endometriosis
Endometrial profiles show genes linked with a high risk for infertility - Osteoporosis
Studies reveal mechanism involved in bone loss caused by estrogen deficiency - Endometrial Cancer
Phytoestrogens in diet found to reduce disease risk - Fetal Diagnosis
MR imaging is a valuable adjunct to ultrasound for prenatal diagnosis - Hormone Replacement Therapy
Combination HRT substantially increases breast cancer risk, large study shows - Osteoporosis
Ibandronate looks promising for the treatment of menopause-related bone loss - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
